The continually evolving role of NMDA receptors in neurobiology and disease.

Graham L Collingridge, Daniel T Monaghan

Journal: Neuropharmacology 2022;210():109042

PMID: 35307365

Full Text on Elsevier Science View on PubMed

Abstract

40 years ago, Jeff Watkins and Richard (Dick) Evans (Watkins and Evans, 1981) published their review on excitatory amino acids. The review, combined with the tools that they and their colleagues developed, significantly changed the field of neurobiology. This Special Issue focused on NMDA receptors is one of six that commemorate this anniversary. The broadest impact of the review, and the work of this group (Collingridge and Abraham, 2022; Evans and Watkins, 2021; Watkins, 2000), was to establish the three receptor scheme for the excitatory, l-glutamate-gated ion channels named for their selective agonists: α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), kainate and N-methyl-d-aspartate (NMDA) (Monaghan et al., 1989; Watkins et al., 1990; Watkins, 2000; Hansen et al., 2021; Lodge, 2009; Watkins and Jane, 2006). The contribution of the Evans and Watkins team was perhaps greatest to the study of NMDA receptors - it was essential. We describe here this fundamental contribution and provide an update on NMDARs as the understanding of their function continues to grow more complex.

Address: Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto and TANZ Centre for Research in Neurodegenerative Diseases, Department of Physiology, University of Toronto, Toronto, ON, Canada.; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA. Electronic address: [email protected].

DOI: 10.1016/j.neuropharm.2022.109042

Link outs

Subscription / membership required

Full Text Sources:

MeSH Terms: Kainic Acid, N-Methylaspartate, Neurobiology, Receptors, N-Methyl-D-Aspartate, alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid